AAAAAA

   
Results: 1-12 |
Results: 12
An oleate desaturase and a suppressor loci direct high oleic acid content of sunflower (Helianthus annuus L.) oil in the Pervenets mutant
Authors: Lacombe, S Kaan, F Leger, S Berville, A
Citation: S. Lacombe et al., An oleate desaturase and a suppressor loci direct high oleic acid content of sunflower (Helianthus annuus L.) oil in the Pervenets mutant, CR AC S III, 324(9), 2001, pp. 839-845
Synthesis of rofecoxib, (MK 0966, Vioxx((R)) 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone), a selective and orally active inhibitor of cyclooxygenase-2
Authors: Therien, M Gauthier, JY Leblanc, Y Leger, S Perrier, H Prasit, P Wang, ZI
Citation: M. Therien et al., Synthesis of rofecoxib, (MK 0966, Vioxx((R)) 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone), a selective and orally active inhibitor of cyclooxygenase-2, SYNTHESIS-S, (12), 2001, pp. 1778-1779
Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx (TM))
Authors: Nicoll-Griffith, DA Yergey, JA Trimble, LA Silva, JM Li, C Chauret, N Gauthier, JY Grimm, E Leger, S Roy, P Therien, M Wang, ZY Prasit, P Zamboni, R Young, RN Brideau, C Chan, CC Mancini, J Riendeau, D
Citation: Da. Nicoll-griffith et al., Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx (TM)), BIOORG MED, 10(23), 2000, pp. 2683-2686
Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar)
Authors: Reifers, F Walsh, EC Leger, S Stainier, DYR Brand, M
Citation: F. Reifers et al., Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar), DEVELOPMENT, 127(2), 2000, pp. 225-235
Inner ear and lateral line expression of a zebrafish Nkx5-1 gene and its downregulation in the ears of FGF8 mutant, ace
Authors: Adamska, M Leger, S Brand, M Hadrys, T Braun, T Bober, E
Citation: M. Adamska et al., Inner ear and lateral line expression of a zebrafish Nkx5-1 gene and its downregulation in the ears of FGF8 mutant, ace, MECH DEVEL, 97(1-2), 2000, pp. 161-165
Structure-based design of COX-2 selectivity into flurbiprofen
Authors: Bayly, CI Black, WC Leger, S Ouimet, N Ouellet, M Percival, MD
Citation: Ci. Bayly et al., Structure-based design of COX-2 selectivity into flurbiprofen, BIOORG MED, 9(3), 1999, pp. 307-312
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors
Authors: Frenette, R Hutchinson, JH Leger, S Therien, M Brideau, C Chan, CC Charleson, S Ethier, D Guay, J Jones, TR McAuliffe, M Piechuta, H Riendeau, D Tagari, P Girard, Y
Citation: R. Frenette et al., Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors, BIOORG MED, 9(16), 1999, pp. 2391-2396
Sar in the alkoxy lactone series: The discovery of DFP, a potent and orally active COX-2 inhibitor
Authors: Leblanc, Y Roy, P Boyce, S Brideau, C Chan, CC Charleson, S Gordon, R Grimm, E Guay, J Leger, S Li, CS Riendeau, D Visco, D Wang, Z Webb, J Xu, LJ Prasit, P
Citation: Y. Leblanc et al., Sar in the alkoxy lactone series: The discovery of DFP, a potent and orally active COX-2 inhibitor, BIOORG MED, 9(15), 1999, pp. 2207-2212
The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor
Authors: Prasit, P Wang, Z Brideau, C Chan, CC Charleson, S Cromlish, W Ethier, D Evans, JF Ford-Hutchinson, AW Gauthier, JY Gordon, R Guay, J Gresser, M Kargman, S Kennedy, B Leblanc, Y Leger, S Mancini, J O'Neill, GP Ouellet, M Percival, MD Perrier, H Riendeau, D Rodger, I Tagari, P Therien, M Vickers, P Wong, E Xu, LJ Young, RN Zamboni, R Boyce, S Rupniak, N Forrest, N Visco, D Patrick, D
Citation: P. Prasit et al., The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor, BIOORG MED, 9(13), 1999, pp. 1773-1778
A fractional Brownian field
Authors: Leger, S Pontier, M
Citation: S. Leger et M. Pontier, A fractional Brownian field, CR AC S I, 329(10), 1999, pp. 893-898
Oxidative bioactivation of the lactol prodrug of a lactone cyclooxygenase-2 inhibitor
Authors: Nicoll-Griffith, DA Falgueyret, JP Silva, JM Morin, PE Trimble, L Chan, CC Clas, S Leger, S Wang, ZY Yergey, JA Riendeau, D
Citation: Da. Nicoll-griffith et al., Oxidative bioactivation of the lactol prodrug of a lactone cyclooxygenase-2 inhibitor, DRUG META D, 27(3), 1999, pp. 403-409
Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles
Authors: Chan, CC Boyce, S Brideau, C Charleson, S Cromlish, W Ethier, D Evans, J Ford-Hutchinson, AW Forrest, MJ Gauthier, JY Gordon, R Gresser, M Guay, J Kargman, S Kennedy, B Leblanc, Y Leger, S Mancini, J O'Neill, GP Ouellet, M Patrick, D Percival, MD Perrier, H Prasit, P Rodger, I Tagari, P Therien, M Vickers, P Visco, D Wang, Z Webb, J Wong, E Xu, LJ Young, RN Zamboni, R Riendeau, D
Citation: Cc. Chan et al., Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles, J PHARM EXP, 290(2), 1999, pp. 551-560
Risultati: 1-12 |